International Stem Cell Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-0.42	-0.21	-0.13	-0.33	-0.9	Upgrade
Depreciation & Amortization	0.22	0.21	0.19	0.22	0.26	Upgrade
Asset Writedown & Restructuring Costs	-	0	-	-	0.25	Upgrade
Stock-Based Compensation	0.29	0.47	0.46	0.4	0.64	Upgrade
Other Operating Activities	0.5	0.36	0.41	0.27	-0.73	Upgrade
Change in Accounts Receivable	0.34	-0.48	0.17	0.1	-0.44	Upgrade
Change in Inventory	-0.39	0.11	0.04	-0.11	-0.27	Upgrade
Change in Accounts Payable	-0.02	-0.18	0.04	-0.19	0.15	Upgrade
Change in Other Net Operating Assets	-0.51	-0.26	-0.26	-0.02	-0.26	Upgrade
Operating Cash Flow	0.01	0.01	0.93	0.33	-1.3	Upgrade
Operating Cash Flow Growth	-38.46%	-98.60%	179.82%	-	-	Upgrade
Capital Expenditures	-0.04	-0.17	-0.08	-0	-0.02	Upgrade
Sale (Purchase) of Intangibles	-0	-0.01	-0	-0.01	-0.02	Upgrade
Investing Cash Flow	-0.05	-0.17	-0.08	-0.01	-0.05	Upgrade
Long-Term Debt Issued	-	-	-	0.25	0.82	Upgrade
Total Debt Issued	-	-	-	0.25	0.82	Upgrade
Long-Term Debt Repaid	-0.2	-0.2	-	-	-	Upgrade
Net Debt Issued (Repaid)	-0.2	-0.2	-	0.25	0.82	Upgrade
Financing Cash Flow	-0.2	-0.2	-	0.25	0.82	Upgrade
Net Cash Flow	-0.24	-0.36	0.85	0.57	-0.52	Upgrade
Free Cash Flow	-0.04	-0.15	0.85	0.33	-1.32	Upgrade
Free Cash Flow Growth	-	-	156.50%	-	-	Upgrade
Free Cash Flow Margin	-0.39%	-1.68%	10.90%	4.05%	-18.39%	Upgrade
Free Cash Flow Per Share	-0.00	-0.02	0.11	0.04	-0.17	Upgrade
Cash Interest Paid	0.01	0.01	0.01	0	0.01	Upgrade
Levered Free Cash Flow	-0	-0.17	0.38	0.27	-0.77	Upgrade
Unlevered Free Cash Flow	0.09	-0.07	0.47	0.35	-0.69	Upgrade
Change in Working Capital	-0.58	-0.81	-0	-0.23	-0.82	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.